Transvenous leads are the most common source of complications associated with the use of implantable cardioverter-defibrillators (ICDs). A preliminary experience with an entirely subcutaneous ICD ...
Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...
Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...
NICE, FRANCE – A longer-term assessment of a new subcutaneous implantable cardioverter defibrillator (ICD) (Boston Scientific) shows that just over 90% of patients are free from complications at two ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
The FDA today approved the Subcutaneous Implantable Defibrillator (S-ICD) system from Cameron Health. The device is the first ICD that does not require a lead that connects directly to the heart and ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Last year the FDA approved Boston Scientific's subcutaneous ICD, the first ICD that can defibrillate the heart without using leads threaded to the heart through the blood vessels. Those leads are the ...
Stockholm, Sweden - Early testing of an implantable cardioverter-defibrillator (ICD) featuring a totally subcutaneous lead system suggests the device can terminate ventricular tachyarrhythmias using ...
Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...
HRS: iPad2 Can Trigger Magnet Mode in Defibrillators The subcutaneous implantable cardioverter-defibrillator (S-ICD System) is both safe and effective for the treatment of life-threatening ventricular ...
This week, a nice article in the Boston Globe appeared on Boston Scientific’s subcutaneous implantable cardiac defibrillator (S-ICD) that recently received FDA approval. It was a fairly balanced ...